Risk of HIV infection in recipients of blood and blood products.
Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Giovanna Orlando, Re T(University of Milan), G Nardi(University of Milan), Paola Cinque(University of California San Diego), Nadia Zanchetta(University of Milan)
PubMed
June 1, 1987
Cited by 0
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Changing incidence of central nervous system diseases in the EuroSIDA cohort
|Annals of Neurology|2004|284
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208